Literature DB >> 27821678

Hospital transmitted Candida auris infections confirmed in the US.

Michael McCarthy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27821678     DOI： 10.1136/bmj.i5978

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.

Authors:  Alexander J Lepak; Miao Zhao; Elizabeth L Berkow; Shawn R Lockhart; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

2.  A TaqMan Probe-Based Real-Time PCR Assay for the Rapid Identification of the Emerging Multidrug-Resistant Pathogen Candida auris on the BD Max System.

Authors:  Amorce Lima; Raymond Widen; Grant Vestal; Dominic Uy; Suzane Silbert
Journal:  J Clin Microbiol       Date:  2019-06-25       Impact factor: 5.948

3.  Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.

Authors:  Milena Kordalewska; Annie Lee; Steven Park; Indira Berrio; Anuradha Chowdhary; Yanan Zhao; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 4.  Drug repurposing for antimicrobial discovery.

Authors:  Maya A Farha; Eric D Brown
Journal:  Nat Microbiol       Date:  2019-03-04       Impact factor: 17.745

Review 5.  Drug repurposing screens and synergistic drug-combinations for infectious diseases.

Authors:  Wei Zheng; Wei Sun; Anton Simeonov
Journal:  Br J Pharmacol       Date:  2017-07-09       Impact factor: 8.739

6.  Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris.

Authors:  Milena Kordalewska; Yanan Zhao; Shawn R Lockhart; Anuradha Chowdhary; Indira Berrio; David S Perlin
Journal:  J Clin Microbiol       Date:  2017-05-24       Impact factor: 5.948

Review 7.  Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris.

Authors:  Andrea Cortegiani; Giovanni Misseri; Teresa Fasciana; Anna Giammanco; Antonino Giarratano; Anuradha Chowdhary
Journal:  J Intensive Care       Date:  2018-10-29

8.  A Novel Actin Binding Drug with In Vivo Efficacy.

Authors:  Akshaya Ravichandran; Mengxin Geng; Kenneth G Hull; Jing Li; Daniel Romo; Shi-En Lu; Aaron Albee; Christopher Nutter; Donna M Gordon; Mahmoud A Ghannoum; Steve W Lockless; Leif Smith
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 9.  Pharmacokinetics and Pharmacodynamics of Ibrexafungerp.

Authors:  Matthew William McCarthy
Journal:  Drugs R D       Date:  2021-12-27

10.  Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to Candida Species.

Authors:  Paige E Negoro; Shuying Xu; Zeina Dagher; Alex Hopke; Jennifer L Reedy; Michael B Feldman; Nida S Khan; Adam L Viens; Natalie J Alexander; Natalie J Atallah; Allison K Scherer; Richard A Dutko; Jane Jeffery; John F Kernien; J Scott Fites; Jeniel E Nett; Bruce S Klein; Jatin M Vyas; Daniel Irimia; David B Sykes; Michael K Mansour
Journal:  mBio       Date:  2020-05-12       Impact factor: 7.786
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.